Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 3546 entries
View as:

A Clinical Evaluation Of BW430C (Lamotrigine) In Bipolar I Disorder- Long-term Extension Of Study SCA104779 (NCT00550407) -

Phase: N/A Priority: Normal
NCT ID: NCT00566020 Org: User:
Start: 05/31/08 End: 10/31/10 Due: 10/31/11

Method Validation Study to Explore the Sensitivity of SenseWear Armband Gecko for Measuring Physical Activity in Subjects With Chronic Obstructive Pulmonary Disease (COPD) & Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02619357 Org: User:
Start: 09/21/15 End: 03/16/16 Due: 03/16/17

GSK706769 A First Time in Human Study For Males and Females

Phase: N/A Priority: Normal
NCT ID: NCT00539201 Org: User:
Start: 09/30/07 End: 02/29/08 Due: 02/28/09

Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488

Phase: N/A Priority: Normal
NCT ID: NCT00307567 Org: User:
Start: 11/30/05 End: 03/31/06 Due: 03/31/07

Effect of Haemodialysis on the Pharmacokinetics of Ezogabine/Retigabine and Its N-acetyl Metabolite

Phase: N/A Priority: Normal
NCT ID: NCT01480609 Org: User:
Start: 11/30/11 End: 04/24/12 Due: 04/24/13

Use of Beta-blockers and Risk of New Onset Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01587638 Org: User:
Start: 04/30/09 End: 12/31/09 Due: 12/31/10

Indirect Cost of Illness Study of Moderate and Severe Asthma in Quebec

Phase: N/A Priority: Normal
NCT ID: NCT02153346 Org: User:
Start: 06/22/14 End: 04/22/16 Due: 04/22/17

BE Study of Metformin GSK 500mg

Phase: N/A Priority: Normal
NCT ID: NCT01710527 Org: User:
Start: 05/09/12 End: 05/18/12 Due: 05/18/13

Dosimetry/Validation Study of 131Iodine-Anti B1 (Murine) Radioimmunotherapy for Chemotherapy Refractory Low Grade B Cell Lymphomas and Low Grade Lymphomas That Have Transformed to Higher Grade Histologies

Phase: N/A Priority: Normal
NCT ID: NCT01224821 Org: User:
Start: 12/31/95 End: 05/31/08 Due: 05/31/09

A Phase I, Randomized, Placebo-controlled, Double Blind, Repeat Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Gastrointestinal Transit Time and Pharmacodynamic Biomarkers of GSK3179106 in Normal Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02798991 Org: User:
Start: 06/30/16 End: 11/30/16 Due: 11/30/17

Immuno & Safety Study of GSK Biologicals' Thio or Preservative Free Hepatitis B Vaccine in Subjects Aged 11-15 Yrs

Phase: N/A Priority: Normal
NCT ID: NCT00343915 Org: User:
Start: 04/21/04 End: 01/10/08 Due: 01/10/09

Study to Evaluate GlaxoSmithKline (GSK) Biologicals' MenC-TT and Hib-MenC-TT or Meningitec™ in Healthy Toddlers

Phase: N/A Priority: Normal
NCT ID: NCT00135564 Org: User:
Start: 01/31/03 End: 07/31/03 Due: 07/31/04

Phase I Study to Assess the Safety, Pharmacokinetics, & Pharmacodynamics of GSK923295 in Subjects w/ Refractory Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00504790 Org: User:
Start: 06/25/07 End: 05/08/12 Due: 05/08/13

A Positron Emission Tomography (PET) Imaging Study to Investigate the Biodistribution and Clearance of an Albumin Binding Domain Antibody (AlbudAb) GSK3128349 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02829307 Org: User:
Start: 08/23/16 End: 01/27/17 Due: 01/27/18

A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00880399 Org: User:
Start: 03/01/09 End: 06/16/10 Due: 06/16/11

A New Oral Treatment For Type II Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00111800 Org: User:
Start: 04/28/05 End: 07/21/06 Due: 07/21/07

Long-Term Follow-Up Studies at Year 6, 7, 8, 9, 10: 2 Formulations of Combined Hepatitis A/B Vaccine Compared in Subjects Aged 12-15 Years

Phase: N/A Priority: Normal
NCT ID: NCT00197119 Org: User:
Start: 05/31/04 End: 06/30/04 Due: 06/30/05

To Evaluate Oral Health and Quality of Life Associated With Use of a Denture Adhesive

Phase: N/A Priority: Normal
NCT ID: NCT03807700 Org: User:
Start: 02/04/19 End: 05/04/19 Due: 05/04/20

Dental Pain (Following Third Molar Tooth Extraction) Study

Phase: N/A Priority: Normal
NCT ID: NCT00114049 Org: User:
Start: 12/31/04 End: 04/30/05 Due: 04/30/06

Risk of Re-Hospitalization in Patients With Chronic Obstructive Pulmonary Disease (COPD) Post Exacerbation

Phase: N/A Priority: Normal
NCT ID: NCT01381458 Org: User:
Start: 09/30/10 End: 03/31/11 Due: 03/31/12

Pharmacokinetic Study Of EPZICOM Tablet

Phase: N/A Priority: Normal
NCT ID: NCT00337922 Org: User:
Start: 07/31/06 End: - Due: -

Study to Assess Safety & Immunogenicity of GSK Biologicals' DTPa/Hib Vaccine vs Separate Administration of DTPa and Hib.

Phase: N/A Priority: Normal
NCT ID: NCT00412854 Org: User:
Start: 01/03/07 End: 06/25/07 Due: 06/25/08

Evaluation of Antibody Persistence and Immune Memory Against the Hepatitis B Antigen in Previously Vaccinated Children

Phase: N/A Priority: Normal
NCT ID: NCT01138098 Org: User:
Start: 06/07/10 End: 11/26/10 Due: 11/26/11

Trial of GSK1120212 and GSK1120212 in Combination With GEM in Japanese Subjects With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01324258 Org: User:
Start: 01/24/11 End: 07/08/13 Due: 07/08/14

Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT00877877 Org: User:
Start: 05/07/09 End: 01/06/15 Due: 01/06/16